Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3397451
Max Phase: Preclinical
Molecular Formula: C28H25F3N4O7S
Molecular Weight: 618.59
Molecule Type: Small molecule
Associated Items:
ID: ALA3397451
Max Phase: Preclinical
Molecular Formula: C28H25F3N4O7S
Molecular Weight: 618.59
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: Cc1cc2c(cc1S(=O)(=O)N1CCN(c3ccc(C(F)(F)F)cc3)CC1)N(CC(=O)c1ccc([N+](=O)[O-])cc1)C(=O)CO2
Standard InChI: InChI=1S/C28H25F3N4O7S/c1-18-14-25-23(34(27(37)17-42-25)16-24(36)19-2-6-22(7-3-19)35(38)39)15-26(18)43(40,41)33-12-10-32(11-13-33)21-8-4-20(5-9-21)28(29,30)31/h2-9,14-15H,10-13,16-17H2,1H3
Standard InChI Key: SDSYCNNGMLFDRP-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 618.59 | Molecular Weight (Monoisotopic): 618.1396 | AlogP: 4.04 | #Rotatable Bonds: 7 |
Polar Surface Area: 130.37 | Molecular Species: NEUTRAL | HBA: 8 | HBD: 0 |
#RO5 Violations: 1 | HBA (Lipinski): 11 | HBD (Lipinski): 0 | #RO5 Violations (Lipinski): 2 |
CX Acidic pKa: | CX Basic pKa: 1.90 | CX LogP: 3.97 | CX LogD: 3.97 |
Aromatic Rings: 3 | Heavy Atoms: 43 | QED Weighted: 0.22 | Np Likeness Score: -1.85 |
1. Konda S, Raparthi S, Bhaskar K, Munaganti RK, Guguloth V, Nagarapu L, Akkewar DM.. (2015) Synthesis and antimicrobial activity of novel benzoxazine sulfonamide derivatives., 25 (7): [PMID:25754493] [10.1016/j.bmcl.2015.01.026] |
Source(1):